2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial by Kellokumpu-Lehtinen, Pirkko-Liisa, Prof, Harmenberg, Ulrika, MD, Joensuu, Timo, MD, McDermott, Ray, MD, Hervonen, Petteri, MD, Ginman, Claes, MD, Luukkaa, Marjaana, MD, Nyandoto, Paul, MD, Hemminki, Akseli, Prof, Nilsson, Sten, Prof, McCaffrey, John, Prof, Asola, Raija, MD, Turpeenniemi-Hujanen, Taina, Prof, Laestadius, Fredrik, MD, Tasmuth, Tiina, MD, Sandberg, Katinka, MD, Keane, Maccon, MD, Lehtinen, Ilari, BSc, Luukkaala, Tiina, MSc, Joensuu, Heikki, Prof

Get full text

Inflammation of actinic keratoses after docetaxel by Kluger, Nicolas, Rentola, Leena, Hervonen, Petteri, Lappalainen, Katriina

Get full text

Biweekly Cabazitaxel Is a Safe Treatment Option for Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients After Docetaxel - A Final Analysis of the Prosty II Trial by Kellokumpu-Lehtinen, Pirkko-Liisa, Marttila, Timo, Jekunen, Antti, Hervonen, Petteri, Klintrup, Katariina, Kataja, Vesa, Utriainen, Tapio, Luukkaa, Marjaana, Leskinen, Markku, Pulkkanen, Kalevi, Kautio, Anna-Liisa, Huttunen, Teppo

Get full text

No Additional Benefit of Adding Ifosfamide to Docetaxel in Castration-resistant Metastatic Prostate Cancer by HERVONEN, Petteri, TULIJOKI, Tapio, KELLOKUMPU-LEHTINEN, Pirkko

Get full text

Multimodal Primary Treatment of Metastatic Prostate Cancer with Androgen Deprivation and Radiation by Joensuu, Timo, Joensuu, Greetta, Kairemo, Kalevi, Kiljunen, Timo, Riener, Maigo, Aaltonen, Aili, Ala-Opas, Martti, Kangasmäki, Aki, Alanko, Tuomo, Taipale, Lauri, Hervonen, Petteri, Bützow, Anna, Virgolini, Irene, Hemminki, Akseli

Get full text

The clinical impact of using complex molecular profiling strategies in routine oncology practice by Laes, Jean-François, Aftimos, Philippe, Barthelemy, Philippe, Bellmunt, Joaquim, Berchem, Guy, Camps, Carlos, Peñas, Ramón de Las, Finzel, Ana, García-Foncillas, Jesús, Hervonen, Petteri, Wahid, Ibrahim, Joensuu, Timo, Kathan, Louis, Kong, Anthony, Mackay, James, Mikropoulos, Christos, Mokbel, Kefah, Mouysset, Jean-Loup, Odarchenko, Sergey, Perren, Timothy J, Pienaar, Rika, Regonesi, Carlos, Alkhayyat, Shadi Salem, El Kinge, Abdul Rahman, Abulkhair, Omalkhair, Galal, Khaled Morsi, Ghanem, Hady, El Karak, Fadi, Garcia, Angel, Ghitti, Gregori, Sadik, Helen

Get full text

Biweekly Docetaxel Is Better Tolerated than Conventional Three-weekly Dosing for Advanced Hormone-refractory Prostate Cancer by HERVONEN, Petteri, JOENSUU, Heikki, MIRJA, Heikkinen, STEN, Nilsson, MARJAANA, Luukkaa, ILARI, Lehtinen, PIRKKO-LIISA, Kellokumpu-Lehtinen, JOENSUU, Timo, CLAES, Ginman, RAY, Mcdermott, ULRIKA, Harmenberg, PAUL, Nyandoto, TIINA, Luukkaala, AKSELI, Hemminki, IGOR, Zaitsev

Get full text

Inflammation of actinic keratoses after docetaxel by Kluger, Nicolas, Rentola, Leena, Hervonen, Petteri, Lappalainen, Katriina

Get full text

Control of arterial tone after long‐term coenzyme Q 10 supplementation in senescent rats by Lönnrot, Kimmo, Pörsti, Ilkka, Alho, Hannu, Wu, Xiumin, Hervonen, Antti, Tolvanen, Jari‐Petteri

Get full text

Control of arterial tone after long‐term coenzyme Q10 supplementation in senescent rats by Lönnrot, Kimmo, Pörsti, Ilkka, Alho, Hannu, Wu, Xiumin, Hervonen, Antti, Tolvanen, Jari‐Petteri

Get full text

Coenzyme Q10 supplementation and recovery from ischemia in senescent rat myocardium by Lönnrot, Kimmo, Tolvanen, Jari-Petteri, Pörsti, Ilkka, Ahola, Tapani, Hervonen, Antti, Alho, Hannu

Get full text

Coenzyme Q 10 supplementation and recovery from ischemia in senescent rat myocardium by Lönnrot, Kimmo, Tolvanen, Jari-Petteri, Pörsti, Ilkka, Ahola, Tapani, Hervonen, Antti, Alho, Hannu

Get full text